Timolol Sustained Release Intraocular Implant (EyeD Pharma)

N/A

Report date: 2024/04/10 17:46:11

Base Information

Drug NameTimolol Sustained Release Intraocular Implant (EyeD Pharma)

Drug Alias NameTimoD implant (EyeD Pharma)Timolol Releasing Intraocular Implant (EyeD Pharma)TimoDTimolol implant (EyeD Pharma)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta adrenergic receptors antagonists

TargetsBeta adrenergic receptors

Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPanamaGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyeD Pharma SA

China Registration ClassN/A

Active CompaniesEyeD Pharma SA

Inactive CompaniesN/A

Active IndicationsGlaucomaOcular Hypertension

Inactive IndicationsGlaucoma, Open-Angle

ATC CodeC07AA06S01ED01